Advancing UHC and Pandemic Preparedness, and Ending Tuberculosis
Strategies to Foster Innovation and Support Greater Access
Amid the current global health crisis, there is a growing urgency on the discussion around Universal Health Coverage (UHC), and pandemic prevention, preparedness, and response (PPR), and ending the tuberculosis (TB) epidemic. As member states discuss the zero drafts of the UHC, PPR, and TB declarations and resolutions ahead of endorsement by heads of state at the UN High-Level Meetings in September 2023, a crucial question remains: How can we foster a sustainable and thriving innovation ecosystem for healthcare that supports Universal Health Coverage and better pandemic preparedness?
This question lies at the heart of an event hosted by Foreign Policy in partnership with the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the body representing the innovative pharmaceutical industry in official relations with the United Nations. The conversation explored the critical role of innovation, and how public and private actors can share efforts and work in partnership to strengthen health systems and improve access to medicines and vaccines.
Gain a deeper understanding of the links between UHC, PPR and TB and engage in a discussion on the role of a sustainable and thriving global health innovation ecosystem in reaching more people, worldwide.
This event was underpinned by new research from FP Analytics, FP’s independent research division. Read the issue brief: “The Road to 2030: Revitalizing Multi-sectoral Partnerships to Achieve Universal Health Coverage.”
For more information, contact Zach Pagovski, Director of Strategic Partnerships.